3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
14
Phase NA
3
Phase 1
2
Phase 4
1
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
2
Conditions
Leukemia, Myeloid, Acute
22
Myelodysplastic Syndromes
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma
12
Leukemia
10
Multiple Myeloma
9
Hodgkin Disease
9
Neuroblastoma
8
Sarcoma
7
Lymphoma, Non-Hodgkin
6
Sarcoma, Ewing
5
Primary Myelofibrosis
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms, Plasma Cell
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Wilms Tumor
4
Rhabdomyosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hematologic Neoplasms
4
Graft vs Host Disease
4
Congenital Abnormalities
4
Central Nervous System Neoplasms
4
Astrocytoma
4
Testicular Neoplasms
3
Retinoblastoma
3
Optic Nerve Glioma
3
Interventions
Cyclophosphamide
5
fludarabine
3
Clofarabine
3
thymoglobulin
2
fludarabine phosphate
2
Vorinostat
2
Polymerase Chain Reaction
2
Methotrexate
2
Isotretinoin
2
Gemtuzumab
2
Flow Cytometry
2
Busulfan
2
Azacitidine
2
Antilymphocyte Serum
2
tipifarnib
1
ruxolitinib
1
merphos
1
imetelstat
1
hydrocortisone hemisuccinate
1
cc-486
1
Whole-Body Irradiation
1
Topotecan
1
Thiotepa
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Radioimmunotherapy
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Mycophenolic Acid
1
MK 2206
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myelomonocytic, Juvenile
×
Busulfan
×
Clear all
NCT01020539
2021-08-06
AML/MDS/JMML
Columbia University
Phase 1
Completed
18 enrolled
NCT00669890
2015-04-22
High Risk
New York Medical College
Phase 1
Terminated
12 enrolled